IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

about

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

Item

http://www.wikidata.org/entity/Q55515909

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@en

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@nl

type

Item

label

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@en

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@nl

prefLabel

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@en

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

@nl

P1476

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

@en

P2093

Gregory T Wolf

http://www.w3.org/2001/XMLSchema#string

James E Egan

http://www.w3.org/2001/XMLSchema#string

Jason G Newman

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Moyer

http://www.w3.org/2001/XMLSchema#string

Michael J Kaplan

http://www.w3.org/2001/XMLSchema#string

Neil L Berinstein

http://www.w3.org/2001/XMLSchema#string

Theresa L Whiteside

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

HPV Associated Head and Neck Cancer

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer

Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12

The role of regulatory T cells in cancer immunology

Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma

Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.

Zinc in cancer prevention.

P304

3731-3746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S165411

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29988729

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6029613

http://www.w3.org/2001/XMLSchema#string